Clipbook | $3,300,000 | (Dec 2, 2025)
Jeeva AI | $9,000,000 | (Dec 2, 2025)
Nevis | $35,000,000 | (Dec 2, 2025)
Certified by Founder
Lodge
Tenvie Therapeutics
start up
United States
- South San Francisco, California
- 09/01/2025
- Unknown
- $200,000,000
Tenvie is a biotechnology company committed to engineering small molecules that transform the treatment of neurological diseases. The company’s foundation is purpose-built with a diverse portfolio of small molecules and a proven team of CNS drug developers to rapidly deliver multiple clinical assets. Tenvie is advancing a pipeline of therapeutics focused on treating neurological, cardiometabolic, and ophthalmic diseases. Its portfolio of wholly owned, highly brain-penetrant, and precision-designed peripherally restricted small molecules address three key drivers of disease: resolving inflammation, rescuing metabolic dysfunction, and restoring lysosomal function.
- Industry Biotechnology Research
- Website https://tenvie.com/
- LinkedIn https://www.linkedin.com/company/tenvie-therapeutics/
Raindrop | $15,000,000 | (Dec 2, 2025)
Mixx Technologies Inc | $33,000,000 | (Dec 2, 2025)
Onton | $7,500,000 | (Dec 2, 2025)
Sokin | $50,000,000 | (Dec 2, 2025)
Tutor | $34,000,000 | (Dec 2, 2025)
Black Forest Labs | $300,000,000 | (Dec 2, 2025)
Marble Imaging | $6,152,690 | (Dec 2, 2025)
Global Work AI | $2,400,000 | (Nov 27, 2025)
Procure Ai | $13,000,000 | (Nov 27, 2025)